Literature DB >> 2956320

Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods.

A M Richards, G Tonolo, G D McIntyre, B J Leckie, J I Robertson.   

Abstract

Plasma atrial natriuretic peptide (ANP) concentrations were measured by both direct radio-immunoassay and with pre-extraction of the peptide from plasma using C18 reverse phase columns. Peptide concentrations were measured in normal subjects (including a group of eight volunteers who received an intravenous infusion of 0.9% NaCl solution), patients with renal failure (including a group with end-stage disease undergoing renal dialysis) and patients with a spectrum of cardiac dysfunction. The overall correlation of results from direct and extracted assay methods was good. However, absolute values from extracted assays were significantly lower than from parallel direct assays. This discrepancy was due to interference from platelets and from another, as yet unidentified, plasma component demonstrated by gel filtration experiments. Extraction of the peptide from plasma by C18 columns largely eliminated these sources of interference and was particularly important for accurate measurement of peptide concentrations within the normal range. Plasma peptide concentrations were elevated in cardiac and renal failure, fell with renal dialysis and rose in normal subjects challenged with an intravenous isotonic fluid load. These findings suggest that ANP participates in the regulation of body fluid volumes and arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956320     DOI: 10.1097/00004872-198704000-00015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  21 in total

1.  Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion.

Authors:  D B Northridge; J McMurray; S Ray; A Jardine; H J Dargie
Journal:  BMJ       Date:  1989-09-02

2.  Atrial natriuretic peptide in the fetus.

Authors:  J C Kingdom; A G Jardine; J Doyle; J M Connell; D H Gilmore; M J Whittle
Journal:  BMJ       Date:  1989-05-06

3.  Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).

Authors:  R M Angus; E A Millar; G W Chalmers; N C Thomson
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

4.  Bronchodilator effect of atrial natriuretic peptide in asthma.

Authors:  G Hulks; A Jardine; J M Connell; N C Thomson
Journal:  BMJ       Date:  1989-10-28

5.  Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

Authors:  A Clerico; G Iervasi; M G Del Chicca; M Emdin; S Maffei; M Nannipieri; L Sabatino; F Forini; C Manfredi; L Donato
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

6.  Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance.

Authors:  C C Lang; T Moreland; A M Choy; T H Pringle; G P McNeill; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Kinetics of atrial natriuretic peptide in young and elderly subjects.

Authors:  A C Tan; T L Jansen; E F Termond; F G Russel; T Thien; P W Kloppenborg; T J Benraad
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Circulating endothelin in acute ischaemic syndromes.

Authors:  S G Ray; J J McMurray; J J Morton; H J Dargie
Journal:  Br Heart J       Date:  1992-05

9.  Early treatment with captopril after acute myocardial infarction.

Authors:  S G Ray; M Pye; K G Oldroyd; J Christie; D T Connelly; D B Northridge; I Ford; J J Morton; H J Dargie; S M Cobbe
Journal:  Br Heart J       Date:  1993-03

Review 10.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.